Patients with pathogenic germline variants showed a trend toward longer PFS and OS, although this was not statistically significant ( Supplementary Figure S4 ).
← all excerpts
Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study.
1
—
—